Cancer‐associated fibroblasts in breast cancer: Challenges and opportunities
D Hu, Z Li, B Zheng, X Lin, Y Pan, P Gong… - Cancer …, 2022 - Wiley Online Library
The tumor microenvironment is proposed to contribute substantially to the progression of
cancers, including breast cancer. Cancer‐associated fibroblasts (CAFs) are the most …
cancers, including breast cancer. Cancer‐associated fibroblasts (CAFs) are the most …
[HTML][HTML] Microfluidic 3D cell culture: from tools to tissue models
Highlights•Comprehensive review of advances in microfluidic 3D cell culture since
2012.•Increased physiological relevance by precise control of cellular microenvironment.• …
2012.•Increased physiological relevance by precise control of cellular microenvironment.• …
[HTML][HTML] Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing
U Marx, TB Andersson, A Bahinski, M Beilmann… - Altex, 2016 - ncbi.nlm.nih.gov
The recent advent of microphysiological systems–microfluidic biomimetic devices that aspire
to emulate the biology of human tissues, organs and circulation in vitro–is envisaged to …
to emulate the biology of human tissues, organs and circulation in vitro–is envisaged to …
Tumor cells and their crosstalk with endothelial cells in 3D spheroids
H Shoval, A Karsch-Bluman, Y Brill-Karniely, T Stern… - Scientific reports, 2017 - nature.com
Recapitulating the tumor microenvironment is a central challenge in the development of
experimental model for cancer. To provide a reliable tool for drug development and for …
experimental model for cancer. To provide a reliable tool for drug development and for …
Recent advances in spheroid-based microfluidic models to mimic the tumour microenvironment
Three-dimensional (3D) multicellular spheroid models can recapitulate the human tumour
microenvironment with more accuracy than conventional cell culture models, as they include …
microenvironment with more accuracy than conventional cell culture models, as they include …
High‐throughput tumor‐on‐a‐chip platform to study tumor–stroma interactions and drug pharmacokinetics
Drug screening in oncology, especially for triple‐negative breast cancer (TNBC), has high
demand but remains unsatisfactory. Currently available models are either nonrepresentative …
demand but remains unsatisfactory. Currently available models are either nonrepresentative …
Microfluidic and paper-based devices for disease detection and diagnostic research
JM Campbell, JB Balhoff, GM Landwehr… - International journal of …, 2018 - mdpi.com
Recent developments in microfluidic devices, nanoparticle chemistry, fluorescent
microscopy, and biochemical techniques such as genetic identification and antibody capture …
microscopy, and biochemical techniques such as genetic identification and antibody capture …
Skin diseases modeling using combined tissue engineering and microfluidic technologies
MH Mohammadi, B Heidary Araghi… - Advanced …, 2016 - Wiley Online Library
In recent years, both tissue engineering and microfluidics have significantly contributed in
engineering of in vitro skin substitutes to test the penetration of chemicals or to replace …
engineering of in vitro skin substitutes to test the penetration of chemicals or to replace …
Tumour associated vasculature-on-a-chip for the evaluation of microbubble-mediated delivery of targeted liposomes
The vascular system is the primary route for the delivery of therapeutic drugs throughout the
body and is an important barrier at the region of disease interest, such as a solid tumour …
body and is an important barrier at the region of disease interest, such as a solid tumour …
Enabling cell recovery from 3D cell culture microfluidic devices for tumour microenvironment biomarker profiling
M Virumbrales-Muñoz, JM Ayuso, A Lacueva… - Scientific Reports, 2019 - nature.com
The tumour microenvironment (TME) has recently drawn much attention due to its profound
impact on tumour development, drug resistance and patient outcome. There is an increasing …
impact on tumour development, drug resistance and patient outcome. There is an increasing …